Nautilus Biotechnology, Inc. (NAUT)

Nautilus Biotechnology Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Nautilus Biotechnology stock has a target of 4.00, which predicts a 65.63% increase from the current stock price of 2.42.

Price Target: $4.00 (+65.63%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$4.00	$4.00	$4.00	$4.00
Change	+65.63%	+65.63%	+65.63%	+65.63%

Analyst Ratings

According to 1 stock analyst, the rating for Nautilus Biotechnology is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Sep '25	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26
Strong Buy	1	1	1	1	1	1
Buy	0	0	0	0	0	0
Hold	1	1	1	1	1	0
Sell	0	0	0	0	0	0
Strong Sell	1	1	1	1	1	0
Total	3	3	3	3	3	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Subbu Nambi Guggenheim	Guggenheim	Strong Buy Maintains $2.5 → $4	Strong Buy	Maintains	$2.5 → $4	+65.63%	Feb 27, 2026
Matthew Sykes Goldman Sachs	Goldman Sachs	Hold → Strong Sell Downgrades $2.25 → $1.75	Hold → Strong Sell	Downgrades	$2.25 → $1.75	-27.54%	Dec 5, 2024
Subbu Nambi Guggenheim	Guggenheim	Strong Buy Initiates $6	Strong Buy	Initiates	$6	+148.45%	Jun 27, 2024
Tycho Peterson Jefferies	Jefferies	Strong Buy → Hold Initiates $5 → $3	Strong Buy → Hold	Initiates	$5 → $3	+24.22%	Jun 3, 2024
Tejas Savant Morgan Stanley	Morgan Stanley	Hold Reiterates $6	Hold	Reiterates	$6	+148.45%	Aug 3, 2023

More Analyst Ratings

Financial Forecast

• Revenue This Year:
  n/a
• Revenue Next Year:
  1.53M
• EPS This Year:
  -0.51

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	-	-	-	1.53M
Revenue Growth	-	-	-	-	-	-	-
EPS	-0.54	-0.60	-0.46	-0.51	-0.56	-0.51	-0.62
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	4	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029	2030
High	n/a	3.2M
Avg	n/a	1.5M
Low	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029	2030
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2025	2026	2027
High	-0.53	-0.59
Avg	-0.51	-0.62
Low	-0.49	-0.65

EPS Growth

EPS Growth	2025	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.